Stay updated on AK104 Monotherapy Plus Axitinib in RCC Clinical Trial
Sign up to get notified when there's something new on the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page.

Latest updates to the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page
- Check3 days agoChange DetectedRevision bumped from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed. There are no substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.8%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.8%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference9%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to AK104 Monotherapy Plus Axitinib in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page.